Carolina P Ramôa1, Marzena M Hiler1, Tory R Spindle1, Alexa A Lopez1, Nareg Karaoghlanian2, Thokozeni Lipato3, Alison B Breland1, Alan Shihadeh4, Thomas Eissenberg1. 1. Center for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, Virginia, USA Department of Psychology, Virginia Commonwealth University, Richmond, Virginia, USA. 2. Department of Mechanical Engineering, American University of Beirut, Beirut, Lebanon. 3. Center for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, Virginia, USA Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA. 4. Center for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, Virginia, USA Department of Mechanical Engineering, American University of Beirut, Beirut, Lebanon.
Abstract
INTRODUCTION: Electronic cigarettes (ECIGs) aerosolise a liquid that usually contains propylene glycol and/or vegetable glycerine, flavourants and the dependence-producing drug, nicotine, in various concentrations. This laboratory study examined the relationship between liquid nicotine concentration and plasma nicotine concentration and puffing behaviour in experienced ECIG users. METHODS: Sixteen ECIG-experienced participants used a 3.3-Volt ECIG battery attached to a 1.5-Ohm dual-coil 'cartomiser' loaded with 1 mL of a flavoured propylene glycol/vegetable glycerine liquid to complete four sessions, at least 2 days apart, that differed by nicotine concentration (0, 8, 18 or 36 mg/mL). In each session, participants completed two 10-puff ECIG-use bouts (30 s puff interval) separated by 60 min. Venous blood was sampled to determine plasma nicotine concentration. Puff duration, volume and average flow rate were measured. RESULTS: Immediately after bout 1, mean plasma nicotine concentration was 5.5 ng/mL (SD=7.7) for 0 mg/mL liquid, with significantly (p<0.05) higher mean concentrations observed for the 8 (mean=17.8 ng/mL, SD=14.6), 18 (mean=25.9 ng/mL, SD=17.5) and 36 mg/mL (mean=30.2 ng/mL; SD=20.0) concentrations; a similar pattern was observed for bout 2. For bout 1, at 36 mg/mL, the mean post- minus pre-bout difference was 24.1 ng/mL (SD=18.3). Puff topography data were consistent with previous results and revealed few reliable differences across conditions. DISCUSSION: This study demonstrates a relationship between ECIG liquid nicotine concentration and user plasma nicotine concentration in experienced ECIG users. Nicotine delivery from some ECIGs may exceed that of a combustible cigarette. The rationale for this higher level of nicotine delivery is uncertain. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
RCT Entities:
INTRODUCTION: Electronic cigarettes (ECIGs) aerosolise a liquid that usually contains propylene glycol and/or vegetable glycerine, flavourants and the dependence-producing drug, nicotine, in various concentrations. This laboratory study examined the relationship between liquid nicotine concentration and plasma nicotine concentration and puffing behaviour in experienced ECIG users. METHODS: Sixteen ECIG-experienced participants used a 3.3-Volt ECIG battery attached to a 1.5-Ohm dual-coil 'cartomiser' loaded with 1 mL of a flavoured propylene glycol/vegetable glycerine liquid to complete four sessions, at least 2 days apart, that differed by nicotine concentration (0, 8, 18 or 36 mg/mL). In each session, participants completed two 10-puff ECIG-use bouts (30 s puff interval) separated by 60 min. Venous blood was sampled to determine plasma nicotine concentration. Puff duration, volume and average flow rate were measured. RESULTS: Immediately after bout 1, mean plasma nicotine concentration was 5.5 ng/mL (SD=7.7) for 0 mg/mL liquid, with significantly (p<0.05) higher mean concentrations observed for the 8 (mean=17.8 ng/mL, SD=14.6), 18 (mean=25.9 ng/mL, SD=17.5) and 36 mg/mL (mean=30.2 ng/mL; SD=20.0) concentrations; a similar pattern was observed for bout 2. For bout 1, at 36 mg/mL, the mean post- minus pre-bout difference was 24.1 ng/mL (SD=18.3). Puff topography data were consistent with previous results and revealed few reliable differences across conditions. DISCUSSION: This study demonstrates a relationship between ECIG liquid nicotine concentration and user plasma nicotine concentration in experienced ECIG users. Nicotine delivery from some ECIGs may exceed that of a combustible cigarette. The rationale for this higher level of nicotine delivery is uncertain. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Robert C McMillen; Mark A Gottlieb; Regina M Whitmore Shaefer; Jonathan P Winickoff; Jonathan D Klein Journal: Nicotine Tob Res Date: 2014-11-06 Impact factor: 4.244
Authors: Rebecca E Bunnell; Israel T Agaku; René A Arrazola; Benjamin J Apelberg; Ralph S Caraballo; Catherine G Corey; Blair N Coleman; Shanta R Dube; Brian A King Journal: Nicotine Tob Res Date: 2014-08-20 Impact factor: 4.244
Authors: Alexa A Lopez; Marzena M Hiler; Eric K Soule; Carolina P Ramôa; Nareg V Karaoghlanian; Thokozeni Lipato; Alison B Breland; Alan L Shihadeh; Thomas Eissenberg Journal: Nicotine Tob Res Date: 2015-09-16 Impact factor: 4.244
Authors: Kathleen R Case; Dale S Mantey; MeLisa R Creamer; Melissa B Harrell; Steven H Kelder; Cheryl L Perry Journal: Addict Behav Date: 2018-03-30 Impact factor: 3.913
Authors: Timothy W Lefever; Youn O K Lee; Alexander L Kovach; Melanie A R Silinski; Julie A Marusich; Brian F Thomas; Jenny L Wiley Journal: Drug Alcohol Depend Date: 2017-01-18 Impact factor: 4.492
Authors: Alison Breland; Robert L Balster; Caroline Cobb; Pebbles Fagan; Jonathan Foulds; J Randy Koch; Thokozeni Lipato; Najat Saliba; Alan Shihadeh; Shumei Sun; Thomas Eissenberg Journal: Am Psychol Date: 2019-04
Authors: Eric K Soule; Joseph G L Lee; Kathleen L Egan; Kendall M Bode; Abigail C Desrosiers; Mignonne C Guy; Alison Breland; Pebbles Fagan Journal: Drug Alcohol Depend Date: 2020-02-05 Impact factor: 4.492